Odonate Therapeutics, Inc. (ODT) [Rocket]

In millions, except per share items	Sep-30-21	Jun-30-21	Dec-31-20	Sep-30-20	Jun-30-20	Mar-31-20	Dec-31-19	Sep-30-19
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues			0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold			0.0	0.0	0.0	0.0	0.0	0.0
Gross profit			0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]			10.4	10.9	11.1	11.2	10.9	10.7
General and administrative			10.4	10.9	11.1	11.2	10.9	10.7
Research and development			117.0	112.8	109.7	105.4	104.0	105.0
EBITDA [+]			-127.0	-123.3	-120.4	-116.1	-114.5	-115.3
EBITDA growth			10.9%	7.0%	7.4%	13.1%	26.6%	50.1%
Depreciation and amortization			0.4	0.4	0.4	0.4	0.4	0.4
EBIT [+]			-127.4	-123.7	-120.8	-116.5	-114.9	-115.7
EBIT growth			10.9%	6.9%	7.3%	13.0%	26.6%	50.2%
Interest income						0.7
Interest income						0.7
Other income (expense), net [+]			0.4	1.1	2.1		2.5	1.7
Other non-operating income			0.4	1.1	2.1		2.5	1.7
Pre-tax income			-126.4	-121.9	-118.1	-113.3	-111.8	-112.7
Income taxes			0.0	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income			-126.4	-121.9	-118.1	-113.3	-111.8	-112.7

Basic EPS [+]			($3.98)	($4.01)	($3.96)	($4.00)	($4.16)	($4.32)
Growth			-4.4%	-7.3%	-11.3%	-2.8%	14.2%	24.4%
Diluted EPS [+]			($3.98)	($4.01)	($3.96)	($4.00)	($4.16)	($4.32)
Growth			-4.4%	-7.3%	-11.3%	-2.8%	14.2%	24.4%

Shares outstanding (basic) [+]			31.7	30.4	29.8	28.3	26.9	26.1
Growth			18.2%	16.7%	21.0%	15.7%	10.0%	19.4%
Shares outstanding (diluted) [+]			31.7	30.4	29.8	28.3	26.9	26.1
Growth			18.2%	16.7%	21.0%	15.7%	10.0%	19.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.